- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03522558
Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting
May 10, 2018 updated by: Candice Rachel Poland, The University of Texas Health Science Center, Houston
Medical Nutrition Therapy for Medically Complex Infants in the Pediatric Outpatient Setting. A Quality Improvement Project
The purpose of this study is to compare standardized nutrition therapy provided by a registered dietitian (RD) at regularly scheduled intervals to usual care in terms of the ability to improve growth parameters in medically complex infants in the pediatric outpatient setting.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 2 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who are admitted between July, 2018 and June, 2019 to the Neonatal High-Risk Clinic (NHRC) and High Risk Children's Clinic (HRCC) at UT Health from a neonatal intensive care unit (NICU)
Exclusion Criteria:
- short bowel syndrome,
- requiring parenteral nutrition (PN)
- active cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Standardized Medical Nutrition Therapy
Standardized Medical Nutrition Therapy will include nutrition assessment provided by a registered dietitian (RD) at initial clinic visit or first Well Child Check (WCC) and regularly scheduled nutrition follow-up at each WCC visit thereafter.
|
Standardized Medical Nutrition Therapy will include nutrition assessment provided by a registered dietitian (RD) at initial clinic visit or first Well Child Check (WCC) and regularly scheduled nutrition follow-up at each WCC visit thereafter.
|
|
ACTIVE_COMPARATOR: Usual Care
At the primary care provider's discretion, a nutrition consult can be requested for the RD to perform nutrition assessment or discuss the patient's plan without full nutrition assessment, as is current practice.
Currently in the Neonatal High-Risk Clinic (NHRC) and High Risk Children's Clinic (HRCC) at UTHealth, providers consult the RD as deemed appropriate with no established criteria for when to include the RD in patient care.
Usual care will not be modified by the study protocol.
|
At the primary care provider's discretion, a nutrition consult can be requested for the RD to perform nutrition assessment or discuss the patient's plan without full nutrition assessment, as is current practice.
Currently in the Neonatal High-Risk Clinic (NHRC) and High Risk Children's Clinic (HRCC) at UTHealth, providers consult the RD as deemed appropriate with no established criteria for when to include the RD in patient care.
Usual care will not be modified by the study protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 4 months corrected gestational age (CGA)
|
4 months corrected gestational age (CGA)
|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 8 months corrected gestational age (CGA)
|
8 months corrected gestational age (CGA)
|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 12 months corrected gestational age (CGA)
|
12 months corrected gestational age (CGA)
|
|
Number of participants with a 20% improvement in growth velocity at 1 year corrected gestational age (CGA)
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with growth failure
Time Frame: 1 year corrected gestational age (CGA)
|
Growth failure ("Failure to Thrive") is defined as crossing 2 growth percentiles in a downward trajectory in the first year of life per child.
|
1 year corrected gestational age (CGA)
|
|
Number of participants who are malnourished
Time Frame: 1 year corrected gestational age (CGA)
|
The Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition (AND/ASPEN) criteria are used for diagnosing pediatric malnutrition.
|
1 year corrected gestational age (CGA)
|
|
Severity of malnutrition as assessed by the AND/ASPEN criteria
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
|
|
Number of emergency department visits
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
|
|
Number of hospitalizations
Time Frame: 1 year corrected gestational age (CGA)
|
1 year corrected gestational age (CGA)
|
|
|
Length of stay
Time Frame: about 3 to 7 days
|
number of hospital days
|
about 3 to 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Candice R Poland, MS, RD, LD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
July 1, 2018
Primary Completion (ANTICIPATED)
June 1, 2019
Study Completion (ANTICIPATED)
June 1, 2019
Study Registration Dates
First Submitted
April 30, 2018
First Submitted That Met QC Criteria
May 10, 2018
First Posted (ACTUAL)
May 11, 2018
Study Record Updates
Last Update Posted (ACTUAL)
May 16, 2018
Last Update Submitted That Met QC Criteria
May 10, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-MS-18-0276
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.